secwatch.observer — SEC 8-K summary
======================================

Issuer:     Averin Capital Acquisition Corp. (ACAA)
CIK:        0002096900
Form:       8-K
Filed at:   2026-05-29T20:30:39+00:00
Accession:  0001213900-26-062863
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Averin Capital Acquisition Corp appoints Akiko Moni Miyashita to board
----------------------------------------------------------------------

- Akiko Moni Miyashita, age 70, appointed to Board effective May 28, 2026.
- She is founder of Beacon Hill Strategy Group; previously served on Halozyme Therapeutics board.
- Over 25 years experience in strategy, finance, corporate development; former EVP and Chief Strategy Officer at Valo Health.
- Signed joinder to letter agreement waiving certain redemption rights and voting in favor of initial business combination.
- Entered into standard director indemnity agreement with the Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2096900/000121390026062863/0001213900-26-062863-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2096900/000121390026062863/ea0292604-8k_averin.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-062863

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer